Search Result "LDL subfractions."
Effect of Fenofibrate on the Concentration and Relative Distribution of LDL Subfractions in Patients with Combined Dyslipidemia
Journal: Letters in Drug Design & Discovery
Volume: 1 Issue: 4 Year: 2004 Page: 380-383
Author(s): V. Tsimihodimos, M. Elisaf, A. Tselepis, A. Tambaki, E. Bairaktari
LDL and HDL Subfractions, Dysfunctional HDL: Treatment Options
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6249-6255
Author(s): Antonio Garcia-Rios, Dragana Nikolic, Pablo Perez-Martinez, Jose Lopez-Miranda, Manfredi Rizzo, Ron C. Hoogeveen
Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome
Journal: Current Vascular Pharmacology
Volume: 17 Issue: 4 Year: 2019 Page: 365-375
Author(s): Michal Kidawa,Anna Gluba-Brzózka,Marzenna Zielinska,Beata Franczyk,Maciej Banach,Jacek Rysz
Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia
Journal: Current Vascular Pharmacology
Volume: 8 Issue: 6 Year: 2010 Page: 820-830
Author(s): Matilda Florentin, Alexadros D. Tselepis, Moses S. Elisaf, Christos V. Rizos, Dimitri P. Mikhailidis, Evangelos N. Liberopoulos
Subfractions and Subpopulations of HDL: An Update
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 25 Year: 2014 Page: 2881-2891
Author(s): M. Rizzo,J. Otvos,D. Nikolic,G. Montalto,P.P. Toth,M. Banach
Electronegative LDL: An Active Player in Atherogenesis or a By- Product of Atherosclerosis?
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1665-1679
Author(s): Andrea Rivas-Urbina,Anna Rull,Jordi Ordóñez-Llanos,José Luis Sánchez-Quesada
New Lipid-lowering Agents Acting on LDL Receptors
Journal: Current Topics in Medicinal Chemistry
Volume: 5 Issue: 3 Year: 2005 Page: 233-242
Author(s): Hubert Scharnagl, Winfried Marz
An Update on the Role of the Quality of LDL in Cardiovascular Risk:The Contribution of the Universities of Palermo and Zurich
Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 2 Issue: 2 Year: 2007 Page: 85-88
Author(s): Manfredi Rizzo, Kaspar Berneis
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos
Biomarkers of Cardiovascular Risk in Haemodialysis Patients
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 39 Year: 2017 Page: 6086-6095
Author(s): Beata Franczyk,Anna Gluba-Brzozka,Jacek Rysz